Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 497,178 | 615,844 | 550,640 | 589,415 |
| Marketable Securities | 508,835 | 403,808 | 1,332,825 | 630,249 |
| Receivables | 231,760 | 192,862 | 222,857 | 401,291 |
| Inventories | 199,100 | 257,358 | 244,712 | 201,672 |
| Other current assets | 135,115 | 164,062 | 165,470 | 152,208 |
| TOTAL | $1,571,988 | $1,633,934 | $2,516,504 | $1,974,835 |
| Non-Current Assets | ||||
| PPE Net | 506,567 | 179,926 | 177,601 | 151,555 |
| Other Non-Current Assets | 260,340 | 680,120 | 314,840 | 52,020 |
| TOTAL | $766,907 | $860,046 | $492,441 | $203,575 |
| Total Assets | $2,338,900 | $2,493,994 | $3,031,124 | $2,205,474 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 116,430 | 0 | 0 |
| Accounts payable and accrued liabilities | 53,530 | 71,210 | 67,310 | 109,500 |
| Accrued Expenses | 54,000 | 124,270 | 134,800 | 143,590 |
| Other current liabilities | 90,220 | 55,610 | 40,830 | 185,890 |
| TOTAL | $221,082 | $381,610 | $1,120,602 | $563,999 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 45,950 | 37,190 | 0 | 0 |
| TOTAL | $45,950 | $56,690 | $N/A | $N/A |
| Total Liabilities | $267,040 | $438,306 | $1,159,130 | $563,999 |
| Shareholders' Equity | ||||
| Common Shares | 1,565,920 | 1,487,280 | 1,273,200 | 1,095,470 |
| Retained earnings | 501,362 | 570,153 | 597,267 | 453,250 |
| Other shareholders' equity | 4,578 | -1,745 | 1,527 | 92,755 |
| TOTAL | $2,071,860 | $2,055,688 | $1,871,994 | $1,641,475 |
| Total Liabilities And Equity | $2,338,900 | $2,493,994 | $3,031,124 | $2,205,474 |